Tiamilal

Tiamilal
(IUPAC) ime
5-(pentan-2-il)-5-(prop-2-en-1-il)-2-fulfaniliden-1,3-diazinan-4,6-dion
Klinički podaci
Robne marke Surital, Thioseconal
AHFS/Drugs.com Monografija
Identifikatori
CAS broj 77-27-0
ATC kod nije dodeljen
PubChem[1][2] 3032285
DrugBank DB01154
ChemSpider[3] 2297298
KEGG[4] C07846 DaY
ChEMBL[5] CHEMBL9536 DaY
Hemijski podaci
Formula C12H18N2O2S 
Mol. masa 254.349
SMILES eMolekuli & PubHem
InChI
InChI=1S/C12H18N2O2S/c1-4-6-8(3)12(7-5-2)9(15)13-11(17)14-10(12)16/h5,8H,2,4,6-7H2,1,3H3,(H2,13,14,15,16,17)
Key: XLOMZPUITCYLMJ-UHFFFAOYSA-N DaY
Fizički podaci
Tačka topljenja 132-133 °C (-75 °F)
Farmakokinetički podaci
Poluvreme eliminacije Poluvreme kod mačaka je 14,3 sata.
Farmakoinformacioni podaci
Trudnoća ?
Pravni status

Tiamilal je barbiturat koji se intravenozno administrira radi ostvarivanja kompletne anestezije u toku kratkih perioda, za indukciju opšte anestezije, i za indukciju hipnotičkog stanja.[6][7][8]

Reference

  1. Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today 15 (23-24): 1052-7. DOI:10.1016/j.drudis.2010.10.003. PMID 20970519.  edit
  2. Evan E. Bolton, Yanli Wang, Paul A. Thiessen, Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry 4: 217-241. DOI:10.1016/S1574-1400(08)00012-1. 
  3. Hettne KM, Williams AJ, van Mulligen EM, Kleinjans J, Tkachenko V, Kors JA. (2010). „Automatic vs. manual curation of a multi-source chemical dictionary: the impact on text mining”. J Cheminform 2 (1): 3. DOI:10.1186/1758-2946-2-3. PMID 20331846.  edit
  4. Joanne Wixon, Douglas Kell (2000). „Website Review: The Kyoto Encyclopedia of Genes and Genomes — KEGG”. Yeast 17 (1): 48–55. DOI:10.1002/(SICI)1097-0061(200004)17:1<48::AID-YEA2>3.0.CO;2-H. 
  5. Gaulton A, Bellis LJ, Bento AP, Chambers J, Davies M, Hersey A, Light Y, McGlinchey S, Michalovich D, Al-Lazikani B, Overington JP. (2012). „ChEMBL: a large-scale bioactivity database for drug discovery”. Nucleic Acids Res 40 (Database issue): D1100-7. DOI:10.1093/nar/gkr777. PMID 21948594.  edit
  6. Martindale, The Extra Pharmacopoeia, 30th ed, p919
  7. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS (2011). „DrugBank 3.0: a comprehensive resource for omics research on drugs”. Nucleic Acids Res. 39 (Database issue): D1035-41. PMID 21059682. 
  8. Wishart DS, Knox C, Guo AC, Cheng D, Shrivastava S, Tzur D, Gautam B, Hassanali M (2008). „DrugBank: a knowledgebase for drugs, drug actions and drug targets”. Nucleic Acids Res 36 (Database issue): D901-6. PMID 18048412. 

Spoljašnje veze

Portal Medicina
Portal Hemija
Tiamilal na Wikimedijinoj ostavi
  • Thiamylal
  • p
  • r
  • u
GABAA receptor
Ultra kratkotrajni
Metoheksital • Tiamilal • Tiopental
Kratko/srednje
trajni
Dugotrajni
Negrupisani
Kratkotrajni
Intermedijerno trajni
Dugotrajni
Dialkil-fenoli
CL-218,872 • Eszopiklon • Indiplon • Nekopidem • Pazinaklon • ROD-188 • Saripidem • Suproklon • Suriklon • SX-3228 • U-89843A • U-90042 • Zaleplon • Zolpidem • Zopiklon
Neuroaktivni
steroidi
Alfa-2 adrenergički
receptor
Melatoninski receptor
Histaminski receptor &
Acetilholinski receptor
5-HT2A &
α1- adrenergički
Selektivni 5-HT2A & α1-adrenergički antagonisti
GABAB receptor /
GHB receptor
GHB Tip
Oreksinski receptori
Oreksinski antagonisti
Drugi receptori/
negrupisani
Drugi

M: PSO/PSI

mepr

dsrd (o,d,b,p,a,s), spes, spvo

proc, lek(N5A/5B/5C/6A/6B/6D)